Read + Share
Amedeo Smart
Independent Medical Education
Mathey G, Epstein J, Alix T, Julien M, et al. Cerebrospinal fluid levels of chitinase 3-like 1 and interleukin-6 can predict response to platform therapies in relapsing multiple sclerosis. J Neurol 2025;272:592.PMID: 40855223
Email
LinkedIn
Privacy Policy